The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000527.5(LDLR):c.2039T>C (p.Leu680Pro)

CA404093609

440674 (ClinVar)

Gene: LDLR (HGNC:3949)
Condition: hypercholesterolemia, familial (MONDO:0007750)
Inheritance Mode: Semidominant inheritance
UUID: 7682bb41-edcc-47f6-b8f4-5b1f2c9f8d26
Approved on: 2025-07-11
Published on: 2025-10-08

HGVS expressions

NM_000527.5:c.2039T>C
NM_000527.5(LDLR):c.2039T>C (p.Leu680Pro)
NC_000019.10:g.11120421T>C
CM000681.2:g.11120421T>C
NC_000019.9:g.11231097T>C
CM000681.1:g.11231097T>C
NC_000019.8:g.11092097T>C
NG_009060.1:g.36041T>C
ENST00000252444.10:c.2297T>C
ENST00000559340.2:c.*108T>C
ENST00000560467.2:c.1919T>C
ENST00000558518.6:c.2039T>C
ENST00000252444.9:c.2293T>C
ENST00000455727.6:c.1535T>C
ENST00000535915.5:c.1916T>C
ENST00000545707.5:c.1606+188T>C
ENST00000557933.5:c.2039T>C
ENST00000558013.5:c.2039T>C
ENST00000558518.5:c.2039T>C
NM_000527.4:c.2039T>C
NM_001195798.1:c.2039T>C
NM_001195799.1:c.1916T>C
NM_001195800.1:c.1535T>C
NM_001195803.1:c.1606+188T>C
NM_001195798.2:c.2039T>C
NM_001195799.2:c.1916T>C
NM_001195800.2:c.1535T>C
NM_001195803.2:c.1606+188T>C
More

Uncertain Significance

Met criteria codes 3
PP3 PP4 PM2
Not Met criteria codes 3
PS4 PP1 PM1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.2039T>C (p.Leu680Pro) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP3 and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 11 July 2025. The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v4.1.0). PM3: REVEL score = 0.918. PP4: Variant meets PM2 and is identified in at least 1 index case who fulfills MEDPED criteria for FH from PMID 27824480 (Gabčová et al., 2017), Slovakia, after alternative causes of high cholesterol were excluded.
Met criteria codes
PP3
REVEL score = 0.918 so PP3 is met.
PP4
PP4_Met: Variant meets PM2 and was identified in 2 related patients who fulfil clinical criteria for FH (MEDPED criteria) from PMID: 27824480, after alternative causes of high cholesterol are excluded
PM2
PM2_Met: This variant is absent from gnomAD (gnomAD v4.1.0);
Not Met criteria codes
PS4
PS4_Not Met: the variant meets PM2 but was identified in 2 related patients who fulfil clinical criteria for FH (MEDPED criteria - PMID: 27824480)
PP1
PP1_Not Met: the variant was reported in only 1 related (1 informative meiosis) from PMID: 27824480, so PP1 is Not Met.
PM1
PM1_Not Met: variant meets PM2 but it is not located in exon 4 (located in exon 14) and is not affecting one of the highly conserved cysteins, so PM1 is not Met.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.